Secondary Osteoporosis: Endocrine and Metabolic Causes of Bone Mass Deterioration

Journal of Osteoporosis - United States
doi 10.1155/2012/907214
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Treatments of Osteoporosis Increase Bone Material Strength Index in Patients With Low Bone Mass

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2020English

THU0497 Is the Secondary Osteoporosis Something Secondary? Experience of a Secondary Osteoporosis Consultation

2018English

Effects of Denosumab on Bone Density, Mass and Strength in Women With Postmenopausal Osteoporosis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2015English

Endocrine and Metabolic Aspects of Tuberculosis

2011English

Endocrine and Metabolic Manifestations of Cancer

BMJ
1972English

Endocrine and Metabolic Manifestations of Cancer.

BMJ
1972English

Vertebral Fractures and Bone Mineral Density in Idiopathic, Secondary and Corticosteroid Associated Osteoporosis in Men

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2000English

Osteoporosis in Multiple Endocrine Neoplasia Type 1

Archives of Surgery
1999English

Osteoporosis—Bone Remodeling and Animal Models

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy